EHNINGEN, Germany, Dec. 17, 2014 /PRNewswire/ -- IBM (NYSE:
IBM) today announced that it is working with Diabetizer, a
German-based healthcare technology company, to leverage IBM's open
platform-as-a-service, Bluemix to build and deploy a
first-of-its-kind, cloud-based application that improves care for
diabetes patients around the world. The app allows diabetes
patients to instantly access and aggregate their health data from
multiple devices anywhere in the world, as well as apply advanced
analytics to control their blood sugar at precisely accurate
levels.
With more than 350 million diabetics worldwide, diabetes remains
one of the greatest health challenges of our generation. Working
with IBM, Diabetizer is changing the way diabetics cope with
managing their disease – many of whom struggle with handwritten
plans and blood sugar logs, guessed biometric data, and manual (and
often inaccurate) estimates at dosage amounts and times. Using
Bluemix, which is powered by a global cloud platform from
SoftLayer, an IBM Company, Diabetizer has built a cloud-based,
analytics-driven app, which moves seamlessly between mobile and web
interfaces to bring new levels of flexibility and precision to
patients, allowing them to:
- Aggregate blood sugar, nutritional and health data from
multiple input sources (i.e. smart phone and web apps) into one,
centralized mobile portal accessible from anywhere in the world –
simplifying records and doctor-patient conversations
- Tap into the Internet of Things to directly integrate biometric
data from wearable devices, analyzing physical activity along with
blood sugar levels to gain a more holistic view of a diabetic's
overall health
"Cloud technology has given us the flexibility and power we need
to build an app that combines patients' most important records into
one, easily usable portal," said Robin Hrassnigg, Diabetizer's
founder and managing director. "Combining this centralized data
with powerful analytics, we're giving the millions of diabetes
sufferers around the world the opportunity for greater mobility,
more accurate treatment and more freedom from constant calculations
and data logging."
The myDIABETIZER app combines a clear evaluation of blood
glucose readings with professional documentation for doctors and
diabetologists, automatically importing measurement data and
setting key parameters based on individual patient needs.
Additionally, the app synchronizes readings taken by blood glucose
measuring devices like iBGStar and GlucoDock with patients'
smartphones, enabling mobile data analysis with advanced analytics
software.
Bluemix is one of the Cloud Foundry Foundation's largest cloud
platform implementations, and – since its beta launch in February
2014 - has helped numerous startups such as Diabetizer turn their
ideas into mobile and web apps and products.
"Diabetizer, one of the first Bluemix customers in the
German-speaking region, is a perfect example of how young companies
can take their business ideas forward with a scalable, flexible,
global cloud infrastructure," said Sandy
Carter, General Manager of Ecosystem Development at IBM.
"Using the cloud to quickly build and bring to market solutions
such as the myDIABETIZER app brings a new level of agility to the
way we develop – allowing us to build apps which can help alleviate
some of our most pressing health issues today."
About IBM Cloud Computing
IBM is the global leader in
open enterprise cloud enabling secure data and infrastructure
integration in the cloud. For more information about cloud
offerings from IBM, visit http://www.ibm.com/cloud. Follow us on
Twitter at @IBMcloud and on our blog at www.thoughtsoncloud.com.
Join the conversation #ibmcloud.
Media Contact:
Nicholas
Smith
IBM Media Relations
212-671-9653
nssmith@us.ibm.com
Logo - http://photos.prnewswire.com/prnh/20090416/IBMLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ibm-cloud-helps-diabetizer-improve-the-accuracy-and-flexibility-of-diabetes-treatment-300011100.html
SOURCE IBM